David Scadden - Director at AGIOS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AGIO on Nasdaq
All Insider Reports
All Insider Reports

David Scadden - trading volume in the past year for AGIOS PHARMACEUTICALS, INC.

Holdings reported by David Scadden for AGIOS PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 17,603 $771,715 $43.84 12 Nov 2025 Direct
Restricted stock units 0 $103,541 $48.84 20 Jun 2025 Direct Common stock
Stock options (right to buy) 26,907 12 Nov 2025 Direct Common stock

Transactions reported by David Scadden for AGIOS PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.